Informational Alert

Due to a measles case in the community, please call before coming to Seattle Children’s if you or your child has potential measles symptoms.

High Priority Alert

Masking and Visitation Changes: Due to high rates of respiratory illnesses in our community, we’ve made changes to our masking and visitation guidelines .

Daniel V Runco, MD, MS

Daniel V Runco, MD, MS

Specialties

"Everything we do as pediatric oncologists should make children live longer or live better – and ideally both. As a pediatric neuro-oncologist, I am thankful to be part of a multidisciplinary team focused solely on improving things for children with cancer and walking through the most difficult days with them and their families. As a researcher, I am passionate about advancing treatments and understanding childhood cancer so our patients can live longer, better lives. "

  • Biography

    Daniel Runco, MD, MS is a Pediatric Oncologist in the Brain Tumor Program at Seattle Children’s Hospital and Assistant Professor at the University of Washington School of Medicine. Dr. Runco joined the faculty in 2024 as a Clinician Scholar with research interests in childhood cancer cachexia. His research is focused around better understanding nutrition and body composition changes that occur during cancer treatment and how that impacts long term survival and quality-of-life. He continues to be active in national and international clinical trials and collaborative societies around treating childhood brain tumors and cancer cachexia.

    Board Certification(s)

    Pediatrics
    Pediatric Hematology-Oncology

    Clinical Interests

    Pediatric neuro-oncology, clinical trials, nutrition, supportive care

    Research Description

    Dr. Runco focuses on identifying, quantifying, and describing childhood cancer cachexia – the muscle loss, weight loss, and body composition changes that occur with a cancer diagnosis and treatment. In addition to better understanding mediators of cachexia, Dr. Runco hopes to identify potential therapeutic targets as in order to mitigate cachexia, improve on-time and optimal cancer therapy delivery, and improve long-term outcomes for survivors of childhood cancers. 

  • Related Resources

  • Patient Testimonials

  • Awards and Honors

    Award Name Award Description Awarded By Award Date
    {{ award.name }} {{ award.description }} {{ award.organization }} {{ award.displayDate }}

  • Publications

    Loading...

    No Publications found for Daniel V Runco, MD, MS

  • Presentations

    Presentation Title Event Location Date
    {{ presentation.title }} {{ presentation.presentedAt }} {{ presentation.location }} {{ presentation.displayDate }}

  • Research Funding

    Grant Title Grantor Amount Award Date
    {{ funding.title }} {{ funding.grantedBy }} {{ funding.amount }} {{ funding.displayDate }}

  • Clinical Trials and Research Studies

    {{ item.t }}

    {{ item.st }}

    {{ item.obj }}

    Condition(s): {{ item.con }} Phase: {{ item.ph }} Clinicaltrials.gov ID: {{ item.nct }}

    No clinical trials found for Daniel V Runco, MD, MS.

Contact Information

Primary Office

Seattle Children's - Hematology-Oncology
4800 Sand Point Way NE
MB.8.501
Seattle, WA 98105
Tel: 206-987-2106

Make an Appointment Refer a Patient

Find a Doctor or Researcher

Type the first or last name you are searching for or select a specialty.

  • Doctor or Researcher Name:
More search options Less search options